Timothy Leary and Richard Alpert’s dismissal from Harvard marked a shift from university-based psychedelic research toward work conducted outside established academic institutions. A faculty dispute became a newspaper story, and the controversy intensified after Harvard placed Leary’s supply of psilocybin under Health Services’ control. By the end of the year, the two had announced that they would continue their research under a new organization rather than the university.

The controversy becomes public

Richard Alpert defended the research as belonging to the tradition of William James and argued that criticism of it threatened academic freedom. Timothy Leary, by contrast, accepted some restrictions that seemed reasonable, and the participants left the faculty discussion believing the dispute had been settled. The next morning, however, the Crimson published the disagreement on its front page. An undergraduate reporter, Robert Ellis Smith, had been taking notes in the crowded room.

Press attention and institutional controls

The Boston Herald soon amplified the story with a headline claiming that 350 students had taken pills, a more dramatic account than the previous day’s report. The dispute made Leary famous, in part because he was willing to give reporters provocative remarks. When Harvard required him to put his Sandoz psilocybin supply under Health Services’ control, he answered with a quip about the panic experienced by people who had not taken psychedelic drugs. The exchange made the institutional conflict itself part of the public spectacle.

Departure from Harvard

By the end of the year, Leary and Alpert had concluded that the substances were too powerful and controversial to be researched in a university setting. In a letter to the Crimson, they announced that they were forming the International Federation for Internal Freedom and would conduct their research under its auspices rather than Harvard’s. They connected the new restrictions to the federal government’s growing authority over experimental drugs, granted to the Food and Drug Administration after the thalidomide tragedy. Their departure was therefore presented not simply as a change of workplace, but as a response to the narrowing conditions under which such research could be done.

From university dispute to underground research

The pair described the new situation as the emergence of a scientific underground and warned that control over the expansion of consciousness would become a civil-liberties issue. Their formulation captured the change in institutional setting: research that had taken place at Harvard was now to continue through an organization outside it. Later accounts of underground psychedelic practice show one strand of the legacy. Guides interviewed decades afterward often traced their professional lineage to Leary, sometimes through one of his graduate students, alongside other early psychedelic therapists. The dismissal thus sits at a boundary in the history presented here: a highly visible academic dispute gave way to a more dispersed practice, even as later research drew on knowledge developed both inside and outside universities.